Search Results - "Stegman, Karen"

Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies by Cao, Xia, Maruyama, Junki, Zhou, Heyue, Fu, Yanwen, Kerwin, Lisa, Powers, Colin, Sattler, Rachel A., Manning, John T., Singh, Alok, Lim, Reyna, Healy, Laura D., Johnson, Sachi, Paz Cabral, Elizabeth, Li, Donghui, Lu, Lucy, Ledesma, Arthur, Lee, Daniel, Richards, Susan, Rivero-Nava, Laura, Li, Yan, Shen, Weiqun, Stegman, Karen, Blair, Benjamin, Urata, Shinji, Kishimoto-Urata, Magumi, Ko, Jamie, Du, Na, Morais, Kyndal, Lawrence, Kate, Rivera, Ianne, Pai, Chin-I., Bresson, Damien, Brunswick, Mark, Zhang, Yanliang, Ji, Henry, Paessler, Slobodan, Allen, Robert D.

“…Coronavirus disease 2019 (COVID-19) continues to significantly impact the global population, thus countermeasure platforms that enable rapid development of…”
Get full text

Chimeric mRNA-based COVID-19 vaccine induces protective immunity against Omicron and Delta variants by Hu, Qidong, Zhao, Ying, Shaabani, Namir, Lyu, Xiaoxuan, Powers, Colin, Sun, Haotian, Cruz, Vincent, Stegman, Karen, Xu, Jia, Fossier, Amber, Huang, Yu, Ho, Giang, Kao, Yi, Wang, Zhihao, Wang, Zhenping, Hu, Yue, Zheng, Yi, Kyaw, Lilian, Zuluaga, Cipriano, Wang, Hua, Pei, Hong, Allen, Robert, Xie, Hui, Ji, Henry, Chen, Runqiang

“…The emerging SARS-CoV-2 variants of concern (VOCs) exhibit enhanced transmission and immune escape, reducing the effectiveness of currently approved mRNA…”
Get full text

Olgotrelvir, a dual inhibitor of SARS-CoV-2 M pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19 by Mao, Long, Shaabani, Namir, Zhang, Xiaoying, Jin, Can, Xu, Wanhong, Argent, Christopher, Kushnareva, Yulia, Powers, Colin, Stegman, Karen, Liu, Jia, Xie, Hui, Xu, Changxu, Bao, Yimei, Xu, Lijun, Zhang, Yuren, Yang, Haigang, Qian, Shengdian, Hu, Yong, Shao, Jianping, Zhang, Can, Li, Tingting, Li, Yi, Liu, Na, Lin, Zhenhao, Wang, Shanbo, Wang, Chao, Shen, Wei, Lin, Yuanlong, Shu, Dan, Zhu, Zhenhong, Kotoi, Olivia, Kerwin, Lisa, Han, Qing, Chumakova, Ludmila, Teijaro, John, Royal, Mike, Brunswick, Mark, Allen, Robert, Ji, Henry, Lu, Hongzhou, Xu, Xiao

“…Oral antiviral drugs with improved antiviral potency and safety are needed to address current challenges in clinical practice for treatment of COVID-19,…”
Get more information

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants by Duty, J Andrew, Kraus, Thomas, Zhou, Heyue, Zhang, Yanliang, Shaabani, Namir, Yildiz, Soner, Du, Na, Singh, Alok, Miorin, Lisa, Li, Donghui, Stegman, Karen, Ophir, Sabrina, Cao, Xia, Atanasoff, Kristina, Lim, Reyna, Mena, Ignacio, Bouvier, Nicole M, Kowdle, Shreyas, Carreño, Juan Manuel, Rivero-Nava, Laura, Raskin, Ariel, Moreno, Elena, Johnson, Sachi, Rathnasinghe, Raveen, Pai, Chin I, Kehrer, Thomas, Cabral, Elizabeth Paz, Jangra, Sonia, Healy, Laura, Singh, Gagandeep, Warang, Prajakta, Simon, Viviana, Sordillo, Emilia Mia, van Bakel, Harm, Liu, Yonghong, Sun, Weina, Kerwin, Lisa, Teijaro, John, Schotsaert, Michael, Krammer, Florian, Bresson, Damien, García-Sastre, Adolfo, Fu, Yanwen, Lee, Benhur, Powers, Colin, Moran, Thomas, Ji, Henry, Tortorella, Domenico, Allen, Robert

“…The continual emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern, in particular the newly emerged Omicron…”
Get more information